Results 311 to 320 of about 185,125 (388)
Proton Pump Inhibitor Use Following Esophageal Variceal Ligation and Its Impact on Clinical Outcomes: Real-World Data from the TriNetX Global Collaborative Network. [PDF]
Amin N+4 more
europepmc +1 more source
Pitstop 2 binds to the clathrin terminal domain. This work explores the nature of the benzylidene moiety, R. The synthesis of 56 novel analogues reveals enhanced potency of a multiple analogues, with catechol‐free 2,3‐dihydroxybenzo[b][1,4]dioxone (54) returning a 1.2 μm IC50, ca 10‐fold more active than Pitstop 2. Pitstop 2, (Z)‐N‐(5‐(4‐bromenzylidene)
Kate Prichard+10 more
wiley +1 more source
Several derivatives incorporating five‐membered aromatic rings are described in this review as bile acid receptor modulators, particularly targeting the farnesoid X receptor and the G protein‐coupled bile acid receptor 1. This review provides a comprehensive analysis of patents and literature that is useful to support researchers in the design of new ...
Claudia Finamore+5 more
wiley +1 more source
Proton pump inhibitor use and risk of stroke: A systematic review and meta-analysis. [PDF]
Feng Y, Zhong Y.
europepmc +1 more source
Molecular Fragmentation as a Strategy to Access Hyperpolarized Compounds from Para‐Hydrogen
Hyperpolarization using para‐hydrogen is a simple and cost‐effective method to dramatically increase sensitivity in magnetic resonance. When combined with chemical reactions that generate smaller fragments, a much wider array of different hyperpolarized molecules can be accessed.
Philip L. Norcott
wiley +1 more source
Seizure and Takotsubo Cardiomyopathy Due to Proton Pump Inhibitor. [PDF]
Acharya I+3 more
europepmc +1 more source
Pemetrexed is a cornerstone in chemo(immunotherapy) of non‐small cell lung cancer and mesothelioma; however, it is contraindicated in patients with renal impairment due to severe toxicity concerns. Therefore, a large proportion of patients is withheld from effective chemo(immunotherapy).
Nikki de Rouw+18 more
wiley +1 more source